Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Acute myeloid leukaemia (AML), Brain (and spinal cord) tumours, Children's cancers, Leukaemia, Neuroblastoma, Sarcoma, Secondary cancers
Closed
Phase 1/2
This trial is for children and young adults with cancer that has come back or continued to grow despite treatment.
It is for children and young adults with one of the following cancers:
a type of leukaemia called acute lymphoblastic leukaemia (ALL) or acute myeloid leukaemia (AML)
neuroblastoma
sarcoma
a type of brain tumour called glioma that usually grows quickly and is likely to spread (high grade glioma)
Everyone taking part needs to be older than 12 months but less than 25 years old. We use the term ‘you’ in this summary, but if you are a parent, we are referring to your child.
Cancer Research UK supports this trial.
Recruitment start: 28 August 2018
Recruitment end: 24 March 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Francis Mussai
Cancer Research UK
University of Birmingham
Innovative Therapies for Children with Cancer in Europe (ITCC)
European Cancer Organisation Methods in Clinical Research workshop
Last reviewed: 03 May 2022
CRUK internal database number: 14953
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
